| 1 |
29077483 | Risk of Late-Onset Alzheimer's Disease by Plasma Cholesterol: Rational In Silico Drug Investigation of Pyrrole-Based HMG-CoA Reductase Inhibitors. | 2017 Oct/Nov |
1 |
| 2 |
26959703 | Genetic insights into statin-associated diabetes risk. | 2016 Apr |
1 |
| 3 |
26566492 | Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia. | 2015 Oct |
2 |
| 4 |
21881526 | Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation. | 2011 Oct |
1 |
| 5 |
16013027 | Activation of small GTPase Ras and renal fibrosis. | 2005 May-Jun |
1 |
| 6 |
16787330 | Statin attenuates high glucose-induced and angiotensin II-induced MAP kinase activity through inhibition of NAD(P)H oxidase activity in cultured mesangial cells. | 2005 Sep |
1 |
| 7 |
15146374 | Inhibition of HMG-CoA reductase with cerivastatin lowers dense low density lipoproteins in patients with elevated fasting glucose, impaired glucose tolerance and type 2 diabetes mellitus. | 2004 May |
1 |
| 8 |
8999918 | "Spot 14" protein functions at the pretranslational level in the regulation of hepatic metabolism by thyroid hormone and glucose. | 1997 Jan 24 |
1 |